胰腺癌立体定向体部放疗中胃肠道短期运动评估及其对剂量学参数的影响
本研究纳入11例接受立体定向体部放疗或质子束治疗的胰腺癌患者,在计划CT上统一生成处方为40 Gy/5次的模拟SBRT计划,利用3次呼气末CT评估胃肠道运动。结果显示,基于计划CT补偿胃肠道运动所需的中位边界,十二指肠为8.0 mm,小肠为14.0 mm;与最差情况下的计划V33相比,十二指肠PRV的V33中位数从0.20 cm³显著增至0.33 cm³(p=0.031)。结论认为胃肠道短期运动导致较大的剂量差异。
要点
- 11例胰腺癌患者统一生成40 Gy/5次模拟SBRT计划,用3次呼气末CT评估胃肠道运动。
- 补偿运动所需中位边界:十二指肠8.0 mm,小肠14.0 mm。
- 十二指肠PRV的V33中位数从0.20 cm³增至0.33 cm³(p=0.031)。
核心结论
- 胃肠道短期运动导致较大的剂量差异。
研究设计与样本
- 纳入11例接受SBRT或质子束治疗的胰腺癌患者。
- 在计划CT上为所有患者生成处方为40 Gy/5次的模拟SBRT计划。
- 使用3次在自主呼气末扫描的CT图像评估胃、十二指肠、小肠和大肠的运动。
- 基于基准点刚性配准后生成各CT图像轮廓并传递至计划CT以评估器官运动。
- 各胃肠道计划危及体积(PRV)通过增加5 mm边界生成,以V33<0.5 cm³作为剂量约束进行评估。
主要发现
- 首次与末次CT扫描的中位间隔为736秒(四分位距IQR:624-986)。
- 基于计划CT补偿胃肠道运动所需的中位边界:十二指肠8.0 mm(IQR:8.0-10.0),小肠14.0 mm(12.0-16.0)。
- 与最差情况下的计划V33相比,十二指肠PRV的V33中位数从0.20 cm³(IQR:0.02-0.26)显著增至0.33 cm³(0.10-0.59),Wilcoxon符号秩检验p=0.031。
关键数值与推荐
- 模拟SBRT计划处方剂量为40 Gy/5次。
- 各胃肠道PRV通过增加5 mm边界生成。
- 剂量约束为V33<0.5 cm³。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The aim of this study is to quantify the short-term motion of the gastrointestinal tract (GI-tract) and its impact on dosimetric parameters in stereotactic body radiation therapy (SBRT) for pancreatic cancer. METHODS: The analyzed patients were eleven pancreatic cancer patients treated with SBRT or proton beam therapy. To ensure a fair analysis, the simulation SBRT plan was generated on the planning CT in all patients with the dose prescription of 40 Gy in 5 fractions. The GI-tract motion (stomach, duodenum, small and large intestine) was evaluated using three CT images scanned at spontaneous expiration. After fiducial-based rigid image registration, the contours in each CT image were generated and transferred to the planning CT, then the organ motion was evaluated. Planning at risk volumes (PRV) of each GI-tract were generated by adding 5 mm margins, and the volume receiving at least 33 Gy (V33) < 0.5 cm3 was evaluated as the dose constraint. RESULTS: The median interval between the first and last CT scans was 736 s (interquartile range, IQR:624-986). To compensate for the GI-tract motion based on the planning CT, the necessary median margin was 8.0 mm (IQR: 8.0-10.0) for the duodenum and 14.0 mm (12.0-16.0) for the small intestine. Compared to the planned V33 with the worst case, the median V33 in the PRV of the duodenum significantly increased from 0.20 cm3 (IQR: 0.02-0.26) to 0.33 cm3 (0.10-0.59) at Wilcoxon signed-rank test (p = 0.031). CONCLUSION: The short-term motions of the GI-tract lead to high dose differences.
引用
- Uchinami Y, Kanehira T, Fujita Y, et al. Evaluation of short-term gastrointestinal motion and its impact on dosimetric parameters in stereotactic body radiation therapy for pancreatic cancer. Clin Transl Radiat Oncol. 2023. PMID: 36686564. doi:10.1016/j.ctro.2023.100576
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。